Intersitial Lung Disease Related To Systemic Sclerosis clinical trials

Explore recruiting intersitial lung disease related to systemic sclerosis clinical trials.

Also recruiting in Europe

Intersitial Lung Disease Related To Systemic Sclerosis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

EvER-ILD 3 : Evaluation of Efficacy and safety of Rituximab and mycophenolate mofetil combination in patients with Interstitial Lung Disease related to systemic sclerosis: a multicentre double-blind placebo-controlled randomized trial.

France

Phase II and Phase III (Integrated) EU CTIS Study details

Intersitial Lung Disease Related To Systemic Sclerosis trials by city

Intersitial Lung Disease Related To Systemic Sclerosis in Toronto Intersitial Lung Disease Related To Systemic Sclerosis in Vancouver Intersitial Lung Disease Related To Systemic Sclerosis in Montreal Intersitial Lung Disease Related To Systemic Sclerosis in Calgary Intersitial Lung Disease Related To Systemic Sclerosis in Edmonton Intersitial Lung Disease Related To Systemic Sclerosis in Ottawa Intersitial Lung Disease Related To Systemic Sclerosis in Winnipeg Intersitial Lung Disease Related To Systemic Sclerosis in Quebec City Intersitial Lung Disease Related To Systemic Sclerosis in Hamilton Intersitial Lung Disease Related To Systemic Sclerosis in Kitchener Intersitial Lung Disease Related To Systemic Sclerosis in London Intersitial Lung Disease Related To Systemic Sclerosis in Halifax Intersitial Lung Disease Related To Systemic Sclerosis in New York Intersitial Lung Disease Related To Systemic Sclerosis in Los Angeles Intersitial Lung Disease Related To Systemic Sclerosis in Chicago Intersitial Lung Disease Related To Systemic Sclerosis in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease